Abstract
The dense granule protein 4 (GRA4) is a granular protein from Toxoplasma gondii, and is a candidate for vaccination against this parasite. In this study, the plasmid pcDNA3.1-GRA4 (pGRA4), encoding for the GRA4 antigen, was incorporated by the dehydration-rehydration method into liposomes composed of 16 mmol/L egg phosphatidylcholine (PC), 8 mmol/L dioleoyl phosphatidylethanolamine (DOPE), and 4 mmol/L 1,2-diodeoyl-3-(trimethylammonium) propane (DOTAP). C57BL/6 mice and BALB/c mice were immunized intramuscularly three times with liposome-encapsulated pGRA4 to determine whether DNA immunization could elicit a protective immune response to T. gondii. Enzyme-linked immunosorbent assay (ELISA) of sera from immunized mice showed that liposome-encapsulated pGRA4 generated high levels of IgG antibodies to GRA4. Production of primary interferon (IFN)-γ and interleukin (IL)-2 in GRA4-stimulated splenocytes from vaccinated mice suggested a modulated Th1-type response. 72.7% of C57BL/6 mice immunized with liposome-encapsulated pGRA4 survived the challenge with 80 tissue cysts of ME49 strain, whereas C57BL/6 mice immunized with pGRA4 had only a survival rate of 54.5%. When immunized BALB/c mice were intraperitoneally challenged with 103 tachyzoites of the highly virulent RH strain, the survival time of mice immunized with liposome-encapsulated pGRA4 was markedly longer than that of other groups. Our observations show that liposome-encapsulated pGRA4 enhanced the protective effect against infection of T. gondii.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aosai, F., Mun, H.S., Norose, K., Chen, M., Hata, H., Kobayashi, M., Kiuchi, M., Stauss, H.J., Yano, A., 1999. Protective immunity induced by vaccination with SAG1 gene-transfected cells against Toxoplasma gondii infection in mice. Microbiology and Immunology, 43(1): 87–91.
Bivas-Benita, M., Laloup, M., Versteyhe, S., Dewitc, J., de Braekeleerc, J., Jongertc, E., Borchard, G., 2003. Generation of Toxoplasma gondii GRA1 protein and DNA vaccine loaded chitosan particles: preparation, characterization, and preliminary in vivo studies. International Journal of Pharmaceutics, 266(1–2):17–27. [doi:10.1016/S0378-5173(03)00377-6]
Brown, C.R., McLeod, R., 1990. Class I MHC genes and CD8+ T cells determine cyst numbers in Toxoplasma gondii infection. The Journal of Immunology, 145(10): 3438–3441.
Buxton, D., Innes, E.A., 1995. A commercial vaccine for ovine toxoplasmosis. Parasitology, 110(s1):S11–S16. [doi:10.1017/S003118200000144X]
Buxton, D., Thomson, K., Maley, S., Wright, S., Bos, H.J., 1991. Vaccination of sheep with a live incomplete strain (S48) of Toxoplasma gondii and their immunity to challenge when pregnant. Vet. Rec., 129(5):89–93.
Caplen, N.J., Alton, E.W., Middleton, P.G., Dorin, J.R., Stevenson, B.J., Gao, X., Durham, S.R., Jeffery, P.K., Hodson, M.E., Coutelle, C., 1995. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nature Medicine, 1(1):39–46. [doi:10.1038/nm0195-39]
Chen, H.F., Chen, G.J., Zheng, H., Guo, H., 2003. Induction of immune responses in mice by vaccination with liposome-entrapped DNA complexes encoding Toxoplasma gondii SAG1 and ROP1 genes. Chinese Medicine Journal, 116(10):1561–1566.
Chen, R., Lu, S.H., Lou, D., Lin, A.F., Zeng, X.J., Ding, Z.Y., Wen, L.Y., Ohta, N., Wang, J.F., Fu, C., 2008. Evaluation of a rapid ELISA technique for detection of circulating antigens of Toxoplasma gondii. Microbiology and Immunology, 52(3):180–187. [doi:10.1111/j.1348-0421.2008.00020.x]
Cong, H., Gu, Q.M., Hong, E.Y., Wang, J.W., Zhao, Q.L., Zhou, H.Y., Li, Y., Zhang, J.Q., 2008. Multi-epitope DNA vaccine linked to the A(2)/B subunit of cholera toxin protect mice against Toxoplasma gondii. Vaccine, 26(31):3913–3921. [doi:10.1016/j.vaccine.2008.04.046]
Couper, K.N., Nielsen, H.V., Petersen, E., Roberts, F., Roberts, C.W., Alexander, J., 2003. DNA vaccination with the immunodominant tachyzoite surface antigen (SAG-1) protects against adult acquired Toxoplasma gondii infection but does not prevent maternofetal transmission. Vaccine, 21(21–22):2813–2820. [doi:10.1016/S0264-410 X(03)00163-4]
Denkers, E.Y., Gazzinelli, R.T., 1998. Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clinical Microbiology Reviews, 11(4):569–588.
Desolme, B., Mévélec, M.N., Buzoni-Gatel, D., Bout, D., 2000. Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4 gene. Vaccine, 18(23): 2512–2521. [doi:10.1016/S0264-410X(00)00035-9]
Fachado, A., Rodriguez, A., Angel, S.O., Pinto, D., Vila, I., Acosta, A., Amendoeira, R.M., Lannes-Vieira, J., 2003. Protective effect of a naked DNA vaccine cocktail against lethal toxoplasmosis in mice. Vaccine, 21(13–14): 1327–1335. [doi:10.1016/S0264-410X(02)00692-8]
Feigin, R.D., Cherry, J.D., 1998. Toxoplasmosis. In: Bergelson, J. (Ed.), Textbook of Pediatric Infectious Diseases, 4th Ed. WB Saunders, Philadelphia, p.2921.
Gaku, S., Takachika, H., Yoko, N., Kenji, S., Kohich, I., Yoshiki, S., Hidemi, T., Mitsuo, H., Jun, K., Hiroshi, K., 2003. HIV mucosal vaccine: nasal immunization with gp160-encapsulated hemagglutinating virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses. The Journal of Immunology, 170:495–502.
Golkar, M., Shokrgozar, M.A., Rafati, S., Musset, K., Assmar, M., Sadaie, R., Cesbron-Delauw, M.F., Mercier, C., 2007. Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice. Vaccine, 25(21):4301–4311. [doi:10.1016/j.vaccine.2007.02.057]
Gregoriadis, G., Saffie, R., Hart, S.L., 1996a. High yield incorporation of plasmid DNA within liposomes: effect on DNA integrity and transfection. Journal of Drug Targeting, 3(6):469–475. [doi:10.3109/10611869609015 966]
Gregoriadis, G., Gursel, I., Gursel, M., McCormack, B., 1996b. Liposomes as immunological adjuvants and vaccine carriers. Journal of Controlled Release, 41(1–2):49–56. [doi:10.1016/0168-3659(96)01355-7]
Gregoriadis, G., Bacon, A., Caparros-Wanderley, W., McCormack, B., 2002. A role for liposomes in genetic vaccination. Vaccine, 20(S5):B1–B9. [doi:10.1016/S0264-410X(02)00514-5]
Happe, S., Fischer, A., Heese, C.H., Reichelt, D., Gruneberg, U., Freund, M., 2002. HIV-associated cerebral toxoplasmosis: review and retrospective analysis of 36 patients. Der Nervenarzt, 73(12):1174–1178. [doi:10.1007/s00115-002-1416-y]
Ismael, A.B., Sekkai, D., Collin, C., Bout, D., Mévélec, M.N., 2003. The MIC3 gene of Toxoplasma gondii is a novel potent vaccine candidate against toxoplasmosis. Infection and Immunity, 71(11):6222–6228. [doi:10.1128/IAI.71.11. 6222-6228.2003]
Khan, I.A., Ely, K.H., Kasper, L.H., 1991. A purified parasite antigen (P30) mediates CD8+ T-cell immunity against fatal Toxoplasma gondii infection in mice. The Journal of Immunology, 147:3501–3506.
Kirby, C., Gregoriadis, G., 1984. Dehydration-rehydration vesicles: a simple method for high yield drug entrapment in liposomes. Biotechnology, 2(11):979–984. [doi:10.1038/nbt1184-979]
Leyva, R., Herion, P., Saavedra, R., 2001. Genetic immunization with plasmid DNA coding for the ROP2 protein of Toxoplasma gondii. Parasitology Research, 87(1):70–79. [doi:10.1007/s004360000296]
Liu, F., Yang, J., Huang, L., Liu, D., 1996. New cationic lipid formulations for gene transfer. Pharmaceutical Research, 13(12):1856–1860. [doi:10.1023/A:1016041326636]
Martin, V., Supanitsky, A., Echeverria, P.C., Litwin, S., Tanos, T., de Roodt, A.R. Guarnera, E.A., Angel, S.O., 2004. Recombinant GRA4 or ROP2 protein combined with alum or the gra4 gene provides partial protection in chronic murine models of toxoplasmosis. Clinical and Diagnostic Laboratory Immunology, 11(4):704–710. [doi:10.1128/CDLI.11.4.704-710.2004]
Mévélec, M.N., Chardés, T., Mercereau-Puijalon, O., Bourguin, I., Achbarou, A., Dubremetz, J.F., Bout, D., 1992. Molecular cloning of GRA4, a Toxoplasma gondii dense granule protein, recognized by mucosal IgA anti-bodies. Molecular and Biochemical Parasitology, 56(2):227–238. [doi:10.1016/0166-6851(92)90172-G]
Mévélec, M.N., Merecerau-Puijalon, O., Buzoni-Gatel, D., Bourguin, I., Chardés, T., Dubremetz, J.F., Bout, D., 1998. Mapping of B epitopes in Gra4, a dense granule antigen of Toxoplasma gondii and protection studies using recombinant proteins administered by the oral route. Parasite Immunology, 20:183–195.
Mévélec, M.N., Bout, D., Desolme, B., Marchand, H., Magné, R., Bruneel, O., Buzoni-Gatel, D., 2005. Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GM-CSF plasmid, against acute, chronical and congenital toxoplasmosis in mice. Vaccine, 23(36):4489–4499. [doi:10.1016/j.vaccine.2005.04.025]
Montgomery, D.L., Ulmer, J.B., Donnelly, J.J., Liu, M.A., 1997. DNA vaccines. Pharmacology & Therapeutics, 74(2):195–207. [doi:10.1016/S0163-7258(97)82003-7]
Nigro, M., Gutierrez, A., Hoffer, A.M., Clemente, M.H., Kaufer, F., Carral, L., Martin, V., Guarnera, E.A., Angel, S.O., 2003. Evaluation of Toxoplasma gondii recombinant proteins for the diagnosis of recently acquired toxoplasmosis by an immunoglobulin G analysis. Diagnostic Microbiology and Infectious Disease, 47(4): 609–613. [doi:10.1016/S0732-8893(03)00156-1]
Parker, S.J., Roberts, C.W., Alexander, J., 1991. CD8+ T cells are the major lymphocyte subpopulation involved in the protective immune response to Toxoplasma gondii in mice. Clinical and Experimental Immunology, 84(2): 207–212.
Perrie, Y., Gregoriadis, G., 2000. Liposome-entrapped plasmid DNA: characterisation studies. Biochimica et Biophysica Acta (BBA), 1475(2):125–132. [doi:10.1016/S0304-4165(00)00055-6]
Perrie, Y., Frederik, P.M., Gregoriadis, G., 2001. Liposome mediated DNA vaccine: the effect of vesicle composition. Vaccine, 19(23–24):3301–3310. [doi:10.1016/S0264-410X(00)00432-1]
Perrie, Y., McNeil, S., Vangala, A., 2003. Liposome-mediated DNA immunisation via the subcutaneous route. Journal of Drug Targeting, 11(8–10):555–563. [doi:10.1080/10611860410001670071]
Remington, J.S., Mcleod, R., Thulliez, P., Desmonts, G., 2006. Infection Diseases of the Fetus and Newborn Infant, 6th Ed. Elsevier Saunders, Philadelphia, p.947–1091. [doi:10.1016/B0-72-160537-0/50033-5]
Rolland, A.P., 1998. From genes to gene medicines: recent advances in nonviral gene delivery. Critical Reviews in Therapeutic Drug Carrier Systems, 15(2):143–198.
Schwartzman, J.D., 2001. Toxoplasmosis. Current Infectious Disease Reports, 3(1):85–89. [doi:10.1007/s11908-001-0063-y]
Stanley, A.C., Buxton, D., Innes, E.A., Huntley, J.F., 2004. Intranasal immunisation with Toxoplasma gondii tachyzoite antigen encapsulated into PLG microspheres induces humoral and cell-mediated immunity in sheep. Vaccine, 22(29–30):3929–3941. [doi:10.1016/j.vaccine.2004.04.022]
Tenter, A.M., Heckeroth, A.R., Weiss, L.M., 2000. Toxoplasma gondii from animals to humans. International Journal for Parasitology, 30(12–13):1217–1258. [doi:10.1016/S0020-7519(00)00124-7]
Tighe, H.M., Roman, C.M., Raz, E., 1998. Gene vaccination: plasmid DNA is more than just a blueprint. Immunology Today, 19(2):89–97. [doi:10.1016/S0167-5699(97)01201-2]
Ulmer, J.B., Donnelly, J.J., Parker, S.E., Rhodes, G.H., Felgner, P.L., Darki, V.J., Gromkowski, S.H., Deck, R.R., DeWitt, C.M., Friedman, A., et al., 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science, 259(5102):1745–1749. [doi:10.1126/science.8456302]
Vercammen, M., Scorza, T., Huygen, K., de Braekeleer, J., Diet, R., Jacobs, D., 2000. DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice. Infection and Immunity, 68(1): 38–45. [doi:10.1128/IAI.68.1.38-45.2000]
Wheeler, C.J., Felgner, P.L., Tsai, Y.J., Marshall, J., Sukhu, L., Doh, S.G., Hartikka, J., Nietupski, J., Manthorpe, M., Nichols, M., et al., 1996. A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung. Proceedings of the National Academy of Sciences USA, 93(21):11454–11459. [doi:10.1073/pnas.93.21.11 454]
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by the Science Foundation of the Health Bureau of Zhejiang Province, China (Nos. 2003QN003 and 2005A001) and the Science Foundation of the Science and Technology Department of Zhejiang Province, China (No. 2006C13022)
Rights and permissions
About this article
Cite this article
Chen, R., Lu, Sh., Tong, Qb. et al. Protective effect of DNA-mediated immunization with liposome-encapsulated GRA4 against infection of Toxoplasma gondii . J. Zhejiang Univ. Sci. B 10, 512–521 (2009). https://doi.org/10.1631/jzus.B0820300
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1631/jzus.B0820300